Overview

A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris

Status:
Completed

Trial end date:
2012-06-01

Target enrollment:

Participant gender:

Summary

This is a Phase 1, single-center, open-label study to evaluate the pharmacokinetics of the BPO metabolites benzoic acid and hippuric acid with 7-day repeat application of GSK2585823 in subjects with acne vulgaris

Phase:

Phase 1

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Benzoic Acid